Adenocarcinoma of the vulva: a case study type mammary gland

Case Report

Published

2021-12-20

How to Cite

Alarcon Andrade, C. ., Rivadeneira Santana, N. ., & Montes, H. D. (2021). Adenocarcinoma of the vulva: a case study type mammary gland: Case Report. Oncology Journal (Ecuador), 31(3), 243–250. https://doi.org/10.33821/567

Issue

Section

Case Reports

Authors

  • Carlos Alarcon Andrade Servicio de Ginecología Oncológica, Instituto Oncológico Nacional “Dr- Juan Tanca Marengo” SOLCA-Guayaquil, Ecuador
  • Nery Rivadeneira Santana Servicio de Ginecología Oncológica, Instituto Oncológico Nacional “Dr- Juan Tanca Marengo” SOLCA-Guayaquil
  • Hector Daniel Montes Departamento de postgado de Cirugía, Universidad de Especialidades Espíritu Santo, Samborondón, Guayaquil

DOI:

https://doi.org/10.33821/567

Keywords:

Vulvar Neoplasms, Vulva, Vulvectomy, Case Reports, Medical Oncology

Abstract

Introduction: Malignant tumors of the vulva are rare tumors of the female genital tract, which represent less than 1% of malignant tumors of the female sex, about 95% of these are squamous cell carcinoma, adenocarcinomas are the least frequent histological type, with 36 cases reported until 2020.

Clinical Case: We present the case of a 36-year-old woman with a history of total hysterectomy due to myomatosis, with a clinical picture of 1 year of evolution characterized by a painless mass in the left labia majora which undergoes a biopsy that reports adenocarcinoma, which is why undergoes radical vulvectomy, the definitive pathological result confirms the diagnosis of adenocarcinoma of the vulva type mammary gland.

Evolution: Radical vulvectomy + bilateral inguino-iliac lymph node dissection was performed. The definitive histopathological study revealed poorly differentiated G3, Unifocal mammary gland adenocarcinoma of the vulva, with metastases in 22/25 right and 30/30 left lymph nodes. One study reported extensive local recurrence, pelvic, retroperitoneal, mediastinal, axillary, cervical and pulmonary lymph node metastases. Paclitaxel 137 mg weekly was started. Chemotherapy was completed up to the 11th week after which he presented a tumor bed infection and died.

Conclusion: In the present case, the clinical course of adenocarcinoma of the vulva type of the mammary gland was aggressive with a survival of less than 5 months.

Downloads

Download data is not yet available.

Author Biographies

Carlos Alarcon Andrade, Servicio de Ginecología Oncológica, Instituto Oncológico Nacional “Dr- Juan Tanca Marengo” SOLCA-Guayaquil, Ecuador

Médico Tratante de Ginecología Oncológica, Instituto Oncológico Nacional Dr. Juan Tanca Marengo SOLCA, Guayaquil. Ecuador.

Nery Rivadeneira Santana, Servicio de Ginecología Oncológica, Instituto Oncológico Nacional “Dr- Juan Tanca Marengo” SOLCA-Guayaquil

Jefe de Servicio de Ginecología Oncológica, Instituto Oncológico Nacional Dr. Juan Tanca Marengo SOLCA, Guayaquil. Ecuador

Hector Daniel Montes, Departamento de postgado de Cirugía, Universidad de Especialidades Espíritu Santo, Samborondón, Guayaquil

Médico Residente de Posgrado, Cirugía General, Instituto Oncológico Nacional Dr. Juan Tanca Marengo SOLCA, Guayaquil. Ecuador. Medico Posgradista Cirugía General, Universidad de Especialidades Espíritu Santo, Samborondón. Ecuador. ORCID: Orcid

Most read articles by the same author(s)